Collaborations

Charles River Laboratories and genOway form North American strategic alliance for drug discovery

Published in Gene Therapy Weekly, June 15th, 2006

Charles River Laboratories, Inc. (CRL), a global provider of solutions that advance the drug discovery and development process, and genOway, the European leader in genetically modified research models, announced the establishment of a three-year North American collaboration.

This strategic alliance will provide pharmaceutical, biotechnology, and academic researchers with innovative research models to better understand human diseases.

genOway holds intellectual property rights to multiple processes for the development of research models and offers a full range of solutions for both gene expression (inducible and conditional transgenic animals,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2006-06-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry